Financials (USD)
Sales 2024 * | 685M | Sales 2025 * | 843M | Capitalization | 3.27B |
---|---|---|---|---|---|
Net income 2024 * | -96M | Net income 2025 * | 6M | EV / Sales 2024 * | 4.3 x |
Net cash position 2024 * | 323M | Net cash position 2025 * | 352M | EV / Sales 2025 * | 3.46 x |
P/E ratio 2024 * |
-34.9
x | P/E ratio 2025 * |
223
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 56.05% |
Latest transcript on HUTCHISON CHINA MED.
Managers | Title | Age | Since |
---|---|---|---|
Wei Guo Su
CEO | Chief Executive Officer | 66 | 04-12-31 |
Chig Fung Cheng
DFI | Director of Finance/CFO | 57 | 08-06-30 |
Michael Shi
CTO | Chief Tech/Sci/R&D Officer | 59 | 21-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Graeme Jack
BRD | Director/Board Member | 73 | 17-02-28 |
Dan Eldar
CHM | Chairman | 70 | 16-07-31 |
Edith Shih
BRD | Director/Board Member | 71 | 99-12-31 |
1st Jan change | Capi. | |
---|---|---|
+63.05% | 856B | |
+39.42% | 631B | |
-4.78% | 359B | |
+17.52% | 325B | |
+8.43% | 297B | |
+14.19% | 244B | |
+5.81% | 234B | |
+16.77% | 226B | |
+14.63% | 177B |